Pharmaceutics · 2019 · 17 citations · 65 references
MedicineImmunologyPharmacologyHypersensitivityMolecular PharmacologyPharmacogeneticsAntiepileptic PharmacologyAutoantigensHla TypingHypersensitivity PharmacologyHypersensitivity ReactionsType I HypersensitivityCarbamazepine PharmacologyHla Antigen PresentationHla Class I MoleculesHla Peptide Binding SpecificityHla-associated Adverse Drug ReactionsHuman Leukocyte Antigen GenotypeMhc Peptide LoadingPeptide Antigen Presentation
Drug hypersensitivity reactions that resemble acute immune reactions are linked to certain human leucocyte antigen (HLA) alleles. Severe and life-threatening Stevens Johnson Syndrome and Toxic Epidermal Necrolysis following treatment with the antiepileptic and psychotropic drug Carbamazepine are associated with HLA-B*15:02; whereas carriers of HLA-A*31:01 develop milder symptoms. It is not understood how these immunogenic differences emerge genotype-specific. For HLA-B*15:02 an altered peptide presentation has been described following exposure to the main metabolite of carbamazepine that is binding to certain amino acids in the F pocket of the HLA molecule. The difference in the molecular mechanism of these diseases has not been comprehensively analyzed, yet; and is addressed in this study. Soluble HLA-technology was utilized to examine peptide presentation of HLA-A*31:01 in presence and absence of carbamazepine and its main metabolite and to examine the mode of peptide loading. Proteome analysis of drug-treated and untreated cells was performed. Alterations in sA*31:01-presented peptides after treatment with carbamazepine revealed different half-life times of peptide-HLA- or peptide-drug-HLA complexes. Together with observed changes in the proteome elicited through carbamazepine or its metabolite these results illustrate the mechanistic differences in carbamazepine hypersensitivity for HLA-A*31:01 or B*15:02 patients and constitute the bridge between pharmacology and pharmacogenetics for personalized therapeutics.
65
Universal sample preparation method for proteome analysis
Jacek R. Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj et al. · Nature Methods · 2009 · 8.7K citations
UniProt: the Universal Protein knowledgebase
Rolf Apweiler · Nucleic Acids Research · 2003 · 7.8K citations · Full text
Causal analysis approaches in Ingenuity Pathway Analysis
A. Krämer, Jeff Green, Jack Pollard et al. · Bioinformatics · 2013 · 6.1K citations · Full text